{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:01:29Z","timestamp":1789524089041,"version":"build-2803163510"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12829-2","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T09:36:51Z","timestamp":1770802611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence and determinants of cardiometabolic comorbidities among people living with HIV receiving antiretroviral therapy at Zewditu Memorial Hospital: evidence from Ethiopia\u2019s longest serving AIDS clinic"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4793-6626","authenticated-orcid":false,"given":"Zekarias","family":"Amdemariam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tewodros","family":"Eshete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rediet","family":"Ambachew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahder","family":"Chufamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishak","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nardos","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Mekonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meaza","family":"Demissie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"12829_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"JD Lundgren","year":"2015","unstructured":"INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infecti on. N Engl J Med. 2015;373:795\u2013807. https:\/\/doi.org\/10.1056\/NEJMoa1506816.","journal-title":"N Engl J Med"},{"key":"12829_CR2","unstructured":"Global Statistics. HIV.gov. https:\/\/www.hiv.gov\/hiv-basics\/overview\/data-and-trends\/global-statistics. Accessed 12 Mar 2025."},{"key":"12829_CR3","doi-asserted-by":"publisher","first-page":"e1001718","DOI":"10.1371\/journal.pmed.1001718","volume":"11","author":"A Boulle","year":"2014","unstructured":"Boulle A, Schomaker M, May MT, Hogg RS, Shepherd BE, Monge S, et al. Mortality in patients with HIV-1 infection starting antiretroviral the Rapy in South Africa, Europe, or North america: a collaborative analys is of prospective studies. PLoS Med. 2014;11:e1001718. https:\/\/doi.org\/10.1371\/journal.pmed.1001718.","journal-title":"PLoS Med"},{"key":"12829_CR4","unstructured":"UNAIDS, UNAIDS Global AIDSU. 2024: The Urgency of now: AIDS at a crossroads. Geneva, Switzerland: UNAIDS; 2024."},{"key":"12829_CR5","doi-asserted-by":"publisher","unstructured":"Hiv\/Aids JUNP on. AIDS, crisis and power to transform (Text extract): UNAIDS global AIDS update 2025 (Executive Summary). Infect Dis Immun. 2024. https:\/\/doi.org\/10.1097\/ID9.0000000000000176.","DOI":"10.1097\/ID9.0000000000000176"},{"key":"12829_CR6","unstructured":"World Health Organization. Non communicable diseases. World Health Organization: Fact Sheets. 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/noncommunicable-diseases. Accessed 12 Mar 2025."},{"key":"12829_CR7","unstructured":"UNAIDS, Global HIV. & AIDS statistics \u2014 Fact sheet. UNAIDS. Availabile from: https:\/\/www.unaids.org\/en\/resources\/fact-sheet. Accessed 27 Sept 2025."},{"issue":"Suppl 1","key":"12829_CR8","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1097\/QAD.0000000000001888","volume":"32","author":"P Patel","year":"2018","unstructured":"Patel P, Rose CE, Collins PY, Nuche-Berenguer B, Sahasrabuddhe VV, Peprah E, et al. Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis. AIDS Lond Engl. 2018;32(Suppl 1):S5\u201320. https:\/\/doi.org\/10.1097\/QAD.0000000000001888.","journal-title":"AIDS Lond Engl"},{"key":"12829_CR9","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","volume":"138","author":"ASV Shah","year":"2018","unstructured":"Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, et al. Global burden of atherosclerotic cardiovascular disease in people livi Ng with HIV: systematic review and Meta-Analysis. Circulation. 2018;138:1100\u201312. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.033369.","journal-title":"Circulation"},{"key":"12829_CR10","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/jac\/dkae116","volume":"79","author":"RL Batterham","year":"2024","unstructured":"Batterham RL, Bedimo RJ, Diaz RS, Guaraldi G, Lo J, Mart\u00ednez E, et al. Cardiometabolic health in people with HIV: expert consensus review. J Antimicrob Chemother. 2024;79:1218\u201333. https:\/\/doi.org\/10.1093\/jac\/dkae116.","journal-title":"J Antimicrob Chemother"},{"key":"12829_CR11","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1210\/jc.2006-2190","volume":"92","author":"VA Triant","year":"2007","unstructured":"Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92:2506\u201312. https:\/\/doi.org\/10.1210\/jc.2006-2190.","journal-title":"J Clin Endocrinol Metab"},{"key":"12829_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/cid\/cis406","volume":"55","author":"KA Armah","year":"2012","unstructured":"Armah KA, McGinnis K, Baker J, Gibert C, Butt AA, Bryant KJ, et al. HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012;55:126\u201336. https:\/\/doi.org\/10.1093\/cid\/cis406.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"12829_CR13","doi-asserted-by":"publisher","first-page":"205031212412606","DOI":"10.1177\/20503121241260613","volume":"12","author":"M Jemal","year":"2024","unstructured":"Jemal M. A review of dolutegravir-associated weight gain and secondary metabolic comorbidities. SAGE Open Med. 2024;12:20503121241260613. https:\/\/doi.org\/10.1177\/20503121241260613.","journal-title":"SAGE Open Med"},{"key":"12829_CR14","doi-asserted-by":"publisher","first-page":"101836","DOI":"10.1016\/j.eclinm.2023.101836","volume":"57","author":"AT Brennan","year":"2023","unstructured":"Brennan AT, Nattey C, Kileel EM, Rosen S, Maskew M, Stokes AC, et al. Change in body weight and risk of hypertension after switching from Efavirenz to dolutegravir in adults living with HIV: evidence from routine care in Johannesburg, South Africa. EClinicalMedicine. 2023;57:101836. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101836.","journal-title":"EClinicalMedicine"},{"key":"12829_CR15","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2147\/IMCRJ.S323233","volume":"14","author":"W Hailu","year":"2021","unstructured":"Hailu W, Tesfaye T, Tadesse A. Hyperglycemia after Dolutegravir-Based antiretroviral therapy. Int Med Case Rep J. 2021;14:503\u20137. https:\/\/doi.org\/10.2147\/IMCRJ.S323233.","journal-title":"Int Med Case Rep J"},{"key":"12829_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40794-015-0007-4","volume":"1","author":"N Peer","year":"2015","unstructured":"Peer N. The converging burdens of infectious and non-communicable diseases in rural-to-urban migrant Sub-Saharan African populations: a focus on HIV\/AIDS, tuberculosis and cardio-metabolic diseases. Trop Dis Travel Med Vaccines. 2015;1:6. https:\/\/doi.org\/10.1186\/s40794-015-0007-4.","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"12829_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5334\/ijic.5839","volume":"22","author":"G McCombe","year":"2022","unstructured":"McCombe G, Lim J, Hout MCV, Lazarus JV, Bachmann M, Jaffar S, et al. Integrating care for diabetes and hypertension with HIV care in Sub-Sa Haran africa: A scoping review. Int J Integr Care. 2022;22:6. https:\/\/doi.org\/10.5334\/ijic.5839.","journal-title":"Int J Integr Care"},{"key":"12829_CR18","unstructured":"Ethiopian Public Health Institute. HIV estimates and projections for Ethiopia: 2024\u20132025. Ethiopian Public Health Institute; 2025."},{"key":"12829_CR19","doi-asserted-by":"publisher","first-page":"e0250328","DOI":"10.1371\/journal.pone.0250328","volume":"16","author":"T Fiseha","year":"2021","unstructured":"Fiseha T, Alemu W, Dereje H, Tamir Z, Gebreweld A. Prevalence of dyslipidaemia among HIV-infected patients receiving comb ination antiretroviral therapy in North Shewa, Ethiopia. PLoS ONE. 2021;16:e0250328. https:\/\/doi.org\/10.1371\/journal.pone.0250328.","journal-title":"PLoS ONE"},{"key":"12829_CR20","volume-title":"Ethiopia STEPS report on risk factors for chronic non-communicable diseases and prevalence of selected NCDs. National survey report","author":"Ethiopian Public Health Institute A","year":"2016","unstructured":"Ethiopian Public Health Institute A. Ethiopia STEPS report on risk factors for chronic non-communicable diseases and prevalence of selected NCDs. National survey report. Addis Ababa: EPHI; 2016."},{"key":"12829_CR21","unstructured":"STEPwise approach to NCD risk factor surveillance (STEPS). https:\/\/www.who.int\/teams\/noncommunicable-diseases\/surveillance\/systems-tools\/steps. Accessed 24 Sept 2022."},{"key":"12829_CR22","unstructured":"Waist circumference and waist. -hip ratio: report of a WHO expert consultation. https:\/\/www.who.int\/publications\/i\/item\/9789241501491. Accessed 5 Mar 2025."},{"key":"12829_CR23","unstructured":"A healthy lifestyle - WHO recommendations. https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/a-healthy-lifestyle---who-recommendations. Accessed 5 Mar 2025."},{"key":"12829_CR24","unstructured":"Definition, Mar, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1, diagnosis and classification of diabetes mellitus. Availabile from: https:\/\/iris.who.int\/handle\/10665\/66040. Accessed 5 2025."},{"key":"12829_CR25","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP)","year":"2001","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert panel on Detection, Evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). JAMA. 2001;285:2486\u201397. https:\/\/doi.org\/10.1001\/jama.285.19.2486.","journal-title":"JAMA"},{"key":"12829_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.smhs.2021.05.001","volume":"3","author":"AD Okely","year":"2021","unstructured":"Okely AD, Kontsevaya A, Ng J, Abdeta C. 2020 WHO guidelines on physical activity and sedentary behavior. Sports Med Health Sci. 2021;3:115\u20138. https:\/\/doi.org\/10.1016\/j.smhs.2021.05.001.","journal-title":"Sports Med Health Sci"},{"key":"12829_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1600-0773.1992.tb00434.x","volume":"70","author":"P Kalix","year":"1992","unstructured":"Kalix P. Cathinone, a natural amphetamine. Pharmacol Toxicol. 1992;70:77\u201386. https:\/\/doi.org\/10.1111\/j.1600-0773.1992.tb00434.x.","journal-title":"Pharmacol Toxicol"},{"key":"12829_CR28","unstructured":"Healthy diet. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/healthy-diet. Accessed 28 Sept 2025."},{"key":"12829_CR29","doi-asserted-by":"publisher","first-page":"2235042X1989931","DOI":"10.1177\/2235042X19899319","volume":"10","author":"Z Getahun","year":"2020","unstructured":"Getahun Z, Azage M, Abuhay T, Abebe F. Comorbidity of HIV, hypertension, and diabetes and associated factors among people receiving antiretroviral therapy in Bahir Dar city, Ethio Pia. J Comorbidity. 2020;10:2235042X19899319. https:\/\/doi.org\/10.1177\/2235042X19899319.","journal-title":"J Comorbidity"},{"key":"12829_CR30","unstructured":"HIV. and noncommunicable disease comorbidities in the era of antiretrov iral therapy: a vital agenda for research in low- and middle-income co untry settings - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/25117958\/. Accessed 4 June 2023."},{"key":"12829_CR31","doi-asserted-by":"publisher","first-page":"e2190395","DOI":"10.1155\/2020\/2190395","volume":"2020","author":"EM Woldesemayat","year":"2020","unstructured":"Woldesemayat EM. Chronic diseases Multimorbidity among adult people living with HIV at Hawassa university comprehensive specialized Hospital, Southern ethiop Ia. Int J Chronic Dis. 2020;2020:e2190395. https:\/\/doi.org\/10.1155\/2020\/2190395.","journal-title":"Int J Chronic Dis"},{"key":"12829_CR32","doi-asserted-by":"publisher","first-page":"e0221022","DOI":"10.1371\/journal.pone.0221022","volume":"14","author":"S Kansiime","year":"2019","unstructured":"Kansiime S, Mwesigire D, Mugerwa H. Prevalence of non-communicable diseases among HIV positive patients on antiretroviral therapy at joint clinical research centre, Lubowa, Uga Nda. PLoS ONE. 2019;14:e0221022. https:\/\/doi.org\/10.1371\/journal.pone.0221022.","journal-title":"PLoS ONE"},{"key":"12829_CR33","unstructured":"Non-communicable diseases. in antiretroviral therapy recipients in Kage ra Tanzania: a cross-sectional study - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/24711874\/. Accessed 4 June 2023."},{"key":"12829_CR34","volume-title":"Consolidated guidelines on the use of antiretroviral drugs for treatin g and preventing HIV infection: recommendations for a public health ap proach","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treatin g and preventing HIV infection: recommendations for a public health ap proach. 2nd ed. Geneva: World Health Organization; 2016.","edition":"2"},{"key":"12829_CR35","volume-title":"HIV related estimates and projections in Ethiopia for the year 2021\u20132022","author":"Ethiopian Public Health Institute","year":"2021","unstructured":"Ethiopian Public Health Institute. HIV related estimates and projections in Ethiopia for the year 2021\u20132022. Ethiopia: EPHI; 2021."},{"key":"12829_CR36","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12889-019-6716-2","volume":"19","author":"D Achwoka","year":"2019","unstructured":"Achwoka D, Waruru A, Chen T-H, Masamaro K, Ngugi E, Kimani M, et al. Noncommunicable disease burden among HIV patients in care: a National retrospective longitudinal analysis of HIV-treatment outcomes in Kenya, 2003\u20132013. BMC Public Health. 2019;19:372. https:\/\/doi.org\/10.1186\/s12889-019-6716-2.","journal-title":"BMC Public Health"},{"key":"12829_CR37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/jhh.2015.97","volume":"30","author":"CU Nduka","year":"2016","unstructured":"Nduka CU, Stranges S, Sarki AM, Kimani PK, Uthman OA. Evidence of increased blood pressure and hypertension risk among Peopl e living with HIV on antiretroviral therapy: a systematic review with meta-analysis. J Hum Hypertens. 2016;30:355\u201362. https:\/\/doi.org\/10.1038\/jhh.2015.97.","journal-title":"J Hum Hypertens"},{"key":"12829_CR38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/QAI.0b013e318221863f","volume":"57","author":"JA Dave","year":"2011","unstructured":"Dave JA, Lambert EV, Badri M, West S, Maartens G, Levitt NS. Effect of nonnucleoside reverse transcriptase inhibitor\u2013based antiretroviral therapy on dysglycemia and insulin sensitivity in South African HIV-infected patients. JAIDS J Acquir Immune Defic Syndr. 2011;57:284\u20139.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"12829_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12879-015-0750-1","volume":"15","author":"T Oni","year":"2015","unstructured":"Oni T, Youngblood E, Boulle A, McGrath N, Wilkinson RJ, Levitt NS. Patterns of HIV, TB, and non-communicable disease multi-morbidity in p eri-urban South Africa- a cross sectional study. BMC Infect Dis. 2015;15:20. https:\/\/doi.org\/10.1186\/s12879-015-0750-1.","journal-title":"BMC Infect Dis"},{"key":"12829_CR40","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","volume":"173","author":"MS Freiberg","year":"2013","unstructured":"Freiberg MS, Chang C-CH, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173:614\u201322. https:\/\/doi.org\/10.1001\/jamainternmed.2013.3728.","journal-title":"JAMA Intern Med"},{"key":"12829_CR41","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2147\/HIV.S275314","volume":"12","author":"D Thet","year":"2020","unstructured":"Thet D, Siritientong T. Antiretroviral Therapy-Associated metabolic complications: review of the recent studies. HIVAIDS Auckl NZ. 2020;12:507\u201324. https:\/\/doi.org\/10.2147\/HIV.S275314.","journal-title":"HIVAIDS Auckl NZ"},{"key":"12829_CR42","unstructured":"National Institutes of Health. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV: cardiovascular complications. ClinicalInfo HIV.gov. 2025. https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/cardiovascular-complications. Accessed 28 Sept 2025."},{"key":"12829_CR43","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1080\/14787210.2020.1757430","volume":"18","author":"P McGettrick","year":"2020","unstructured":"McGettrick P, Mallon PWG, Sabin CA. Cardiovascular disease in HIV patients: recent advances in predicting and managing risk. Expert Rev Anti Infect Ther. 2020;18:677\u201388. https:\/\/doi.org\/10.1080\/14787210.2020.1757430.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"12829_CR44","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/COH.0b013e3282f6a613","volume":"3","author":"CA Sabin","year":"2008","unstructured":"Sabin CA, Worm SW. Conventional cardiovascular risk factors in HIV infection: how conventional are they? Curr Opin HIV AIDS. 2008;3:214\u20139. https:\/\/doi.org\/10.1097\/COH.0b013e3282f6a613.","journal-title":"Curr Opin HIV AIDS"},{"key":"12829_CR45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1742-6405-9-31","volume":"9","author":"A Tadewos","year":"2012","unstructured":"Tadewos A, Addis Z, Ambachew H, Banerjee S. Prevalence of dyslipidemia among HIV-infected patients using first-lin e highly active antiretroviral therapy in Southern ethiopia: a cross-s ectional comparative group study. AIDS Res Ther. 2012;9:31. https:\/\/doi.org\/10.1186\/1742-6405-9-31.","journal-title":"AIDS Res Ther"},{"key":"12829_CR46","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2147\/HIV.S252391","volume":"12","author":"A Kemal","year":"2020","unstructured":"Kemal A, Teshome MS, Ahmed M, Molla M, Malik T, Mohammed J, et al. Dyslipidemia and associated factors among adult patients on antiretrov Iral therapy in armed force comprehensive and specialized Hospital, ad dis Ababa, Ethiopia. HIVAIDS Auckl NZ. 2020;12:221\u201331. https:\/\/doi.org\/10.2147\/HIV.S252391.","journal-title":"HIVAIDS Auckl NZ"},{"key":"12829_CR47","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/2325957415614642","volume":"15","author":"W Ombeni","year":"2016","unstructured":"Ombeni W, Kamuhabwa AR. Lipid profile in HIV-Infected patients using First-Line antiretroviral drugs. J Int Assoc Provid AIDS Care. 2016;15:164\u201371. https:\/\/doi.org\/10.1177\/2325957415614642.","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"12829_CR48","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/1471-2458-14-236","volume":"14","author":"CE Bekolo","year":"2014","unstructured":"Bekolo CE, Nguena MB, Ewane L, Bekoule PS, Kollo B. The lipid profile of HIV-infected patients receiving antiretroviral Th erapy in a rural Cameroonian population. BMC Public Health. 2014;14:236. https:\/\/doi.org\/10.1186\/1471-2458-14-236.","journal-title":"BMC Public Health"},{"key":"12829_CR49","doi-asserted-by":"publisher","first-page":"e0238114","DOI":"10.1371\/journal.pone.0238114","volume":"15","author":"A Gebrie","year":"2020","unstructured":"Gebrie A. Hypertension among people living with human immunodeficiency virus rec eiving care at referral hospitals of Northwest ethiopia: A cross-secti onal study. PLoS ONE. 2020;15:e0238114. https:\/\/doi.org\/10.1371\/journal.pone.0238114.","journal-title":"PLoS ONE"},{"key":"12829_CR50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/HIV.S176877","volume":"10","author":"Z Ataro","year":"2018","unstructured":"Ataro Z, Ashenafi W, Fayera J, Abdosh T. Magnitude and associated factors of diabetes mellitus and hypertension among adult HIV-positive individuals receiving highly active antiretroviral therapy at jugal Hospital, Harar, Ethiopia. HIVAIDS Auckl NZ. 2018;10:181\u201392. https:\/\/doi.org\/10.2147\/HIV.S176877.","journal-title":"HIVAIDS Auckl NZ"},{"key":"12829_CR51","doi-asserted-by":"publisher","first-page":"e011175","DOI":"10.1136\/bmjopen-2016-011175","volume":"6","author":"SM Abebe","year":"2016","unstructured":"Abebe SM, Getachew A, Fasika S, Bayisa M, Girma Demisse A, Mesfin N. Diabetes mellitus among HIV-infected individuals in follow-up care at university of Gondar Hospital, Northwest Ethiopia. BMJ Open. 2016;6:e011175. https:\/\/doi.org\/10.1136\/bmjopen-2016-011175.","journal-title":"BMJ Open"},{"key":"12829_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/ISRR\/2013\/1897","volume":"1","author":"V Sachithananthan","year":"2012","unstructured":"Sachithananthan V, Loha E, Gose M. Prevalence of diabetes mellitus, hypertension and lipodystrophy in HAART receiving HIV patients in Southern Ethiopia. Int STD Res Rev. 2012;1:1\u201311.","journal-title":"Int STD Res Rev"},{"key":"12829_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4102\/phcfm.v11i1.1974","volume":"11","author":"R Chireshe","year":"2019","unstructured":"Chireshe R, Naidoo K, Nyamakura R. Hypertension among human immunodeficiency virus infected patients on t reatment at Parirenyatwa hospital: A descriptive study. Afr J Prim Health Care Fam Med. 2019;11:1\u20138. https:\/\/doi.org\/10.4102\/phcfm.v11i1.1974.","journal-title":"Afr J Prim Health Care Fam Med"},{"key":"12829_CR54","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.jash.2017.06.004","volume":"11","author":"Y Xu","year":"2017","unstructured":"Xu Y, Chen X, Wang K. Global prevalence of hypertension among people living with HIV: a syst ematic review and meta-analysis. J Am Soc Hypertens JASH. 2017;11:530\u201340. https:\/\/doi.org\/10.1016\/j.jash.2017.06.004.","journal-title":"J Am Soc Hypertens JASH"},{"key":"12829_CR55","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/QAI.0000000000000168","volume":"66","author":"M Myerson","year":"2014","unstructured":"Myerson M, Poltavskiy E, Armstrong EJ, Kim S, Sharp V, Bang H. Prevalence, treatment, and control of dyslipidemia and hypertension in 4278 HIV outpatients. J Acquir Immune Defic Syndr 1999. 2014;66:370\u20137. https:\/\/doi.org\/10.1097\/QAI.0000000000000168.","journal-title":"J Acquir Immune Defic Syndr 1999"},{"key":"12829_CR56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13098-020-00527-1","volume":"12","author":"A Gebrie","year":"2020","unstructured":"Gebrie A, Tesfaye B, Gebru T, Adane F, Abie W, Sisay M. Diabetes mellitus and its associated risk factors in patients with Hum an immunodeficiency virus on anti-retroviral therapy at referral hospi Tals of Northwest Ethiopia. Diabetol Metab Syndr. 2020;12:20. https:\/\/doi.org\/10.1186\/s13098-020-00527-1.","journal-title":"Diabetol Metab Syndr"},{"key":"12829_CR57","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13104-019-4402-1","volume":"12","author":"T Fiseha","year":"2019","unstructured":"Fiseha T, Belete AG. Diabetes mellitus and its associated factors among human immunodeficiency virus-infected patients on anti-retroviral therapy in Northeast Ethiopia. BMC Res Notes. 2019;12:372. https:\/\/doi.org\/10.1186\/s13104-019-4402-1.","journal-title":"BMC Res Notes"},{"key":"12829_CR58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2147\/DMSO.S80084","volume":"8","author":"AE Mohammed","year":"2015","unstructured":"Mohammed AE, Shenkute TY, Gebisa WC. Diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University specialized Hospital, Southwest Ethiopia. Diabetes Metab Syndr Obes. 2015;8:197\u2013206. https:\/\/doi.org\/10.2147\/DMSO.S80084.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"12829_CR59","first-page":"221","volume":"50","author":"Y Feleke","year":"2012","unstructured":"Feleke Y, Fekade D, Mezegebu Y. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients. Ethiop Med J. 2012;50:221\u201330.","journal-title":"Ethiop Med J"},{"key":"12829_CR60","doi-asserted-by":"publisher","first-page":"960178","DOI":"10.5402\/2012\/960178","volume":"2012","author":"B Omech","year":"2012","unstructured":"Omech B, Sempa J, Castelnuovo B, Opio K, Otim M, Mayanja-Kizza H, et al. Prevalence of HIV-Associated metabolic abnormalities among patients Ta King First-Line antiretroviral therapy in Uganda. Isrn Aids. 2012;2012:960178. https:\/\/doi.org\/10.5402\/2012\/960178.","journal-title":"Isrn Aids"},{"key":"12829_CR61","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1186\/s12889-016-3916-x","volume":"16","author":"OH Divala","year":"2016","unstructured":"Divala OH, Amberbir A, Ismail Z, Beyene T, Garone D, Pfaff C, et al. The burden of hypertension, diabetes mellitus, and cardiovascular risk factors among adult Malawians in HIV care: consequences for integrate d services. BMC Public Health. 2016;16:1243. https:\/\/doi.org\/10.1186\/s12889-016-3916-x.","journal-title":"BMC Public Health"},{"key":"12829_CR62","doi-asserted-by":"publisher","first-page":"e0134410","DOI":"10.1371\/journal.pone.0134410","volume":"10","author":"E Maganga","year":"2015","unstructured":"Maganga E, Smart LR, Kalluvya S, Kataraihya JB, Saleh AM, Obeid L, et al. Glucose metabolism Disorders, HIV and antiretroviral therapy among Tan Zanian adults. PLoS ONE. 2015;10:e0134410. https:\/\/doi.org\/10.1371\/journal.pone.0134410.","journal-title":"PLoS ONE"},{"key":"12829_CR63","doi-asserted-by":"publisher","first-page":"e0194819","DOI":"10.1371\/journal.pone.0194819","volume":"13","author":"YF Gebreyes","year":"2018","unstructured":"Gebreyes YF, Goshu DY, Geletew TK, Argefa TG, Zemedu TG, Lemu KA, et al. Prevalence of high bloodpressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in ethiopia: evidences from the National NCDs STEPS Survey, 2015. PLoS ONE. 2018;13:e0194819. https:\/\/doi.org\/10.1371\/journal.pone.0194819.","journal-title":"PLoS ONE"},{"key":"12829_CR64","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12982-025-00589-4","volume":"22","author":"A Getie","year":"2025","unstructured":"Getie A, Ayenew T, Gedfew M, Amlak BT. Dyslipidemia and its associated factors in ethiopia: a systematic review and meta-analysis. Discov Public Health. 2025;22:232. https:\/\/doi.org\/10.1186\/s12982-025-00589-4.","journal-title":"Discov Public Health"},{"key":"12829_CR65","doi-asserted-by":"publisher","first-page":"100132","DOI":"10.1016\/j.obmed.2019.100132","volume":"15","author":"KG Bishu","year":"2019","unstructured":"Bishu KG, Jenkins C, Yebyo HG, Atsbha M, Wubayehu T, Gebregziabher M. Diabetes in ethiopia: A systematic review of prevalence, risk factors, complications, and cost. Obes Med. 2019;15:100132. https:\/\/doi.org\/10.1016\/j.obmed.2019.100132.","journal-title":"Obes Med"},{"key":"12829_CR66","doi-asserted-by":"publisher","first-page":"e0244642","DOI":"10.1371\/journal.pone.0244642","volume":"15","author":"SA Tiruneh","year":"2020","unstructured":"Tiruneh SA, Bukayaw YA, Yigizaw ST, Angaw DA. Prevalence of hypertension and its determinants in ethiopia: A systematic review and meta-analysis. PLoS ONE. 2020;15:e0244642. https:\/\/doi.org\/10.1371\/journal.pone.0244642.","journal-title":"PLoS ONE"},{"key":"12829_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-14-904","volume":"14","author":"GB Kagaruki","year":"2014","unstructured":"Kagaruki GB, Mayige MT, Ngadaya ES, Kimaro GD, Kalinga AK, Kilale AM, et al. Magnitude and risk factors of non-communicable diseases among people l Iving with HIV in tanzania: a cross sectional study from Mbeya and Dar Es Salaam regions. BMC Public Health. 2014;14:1\u20139. https:\/\/doi.org\/10.1186\/1471-2458-14-904.","journal-title":"BMC Public Health"},{"key":"12829_CR68","doi-asserted-by":"publisher","first-page":"e621565","DOI":"10.5402\/2012\/621565","volume":"2012","author":"A Diouf","year":"2012","unstructured":"Diouf A, Cournil A, Ba-Fall K, Ngom-Gu\u00e8ye NF, Eymard-Duvernay S, Ndiaye I, et al. Diabetes and hypertension among patients receiving antiretroviral Trea tment since 1998 in senegal: prevalence and associated factors. Int Sch Res not. 2012;2012:e621565. https:\/\/doi.org\/10.5402\/2012\/621565.","journal-title":"Int Sch Res not"},{"key":"12829_CR69","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/01.CIR.0000048893.62841.F7","volume":"107","author":"EG Lakatta","year":"2003","unstructured":"Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Circulation. 2003;107:346\u201354. https:\/\/doi.org\/10.1161\/01.CIR.0000048893.62841.F7.","journal-title":"Circulation"},{"key":"12829_CR70","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S1473-3099(15)00056-0","volume":"15","author":"M Smit","year":"2015","unstructured":"Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, van Sighem A, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis. 2015;15:810\u20138. https:\/\/doi.org\/10.1016\/S1473-3099(15)00056-0.","journal-title":"Lancet Infect Dis"},{"key":"12829_CR71","doi-asserted-by":"publisher","unstructured":"Wang X, Yang C, Jiang J, Hu Y, Hao Y, Dong J-Y. Polypharmacy, chronic kidney disease, and mortality among older adults: a prospective study of National health and nutrition examination survey, 1999\u20132018. Front Public Health. 2023;11. https:\/\/doi.org\/10.3389\/fpubh.2023.1116583.","DOI":"10.3389\/fpubh.2023.1116583"},{"key":"12829_CR72","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1093\/infdis\/jix518","volume":"216","author":"J Gallant","year":"2017","unstructured":"Gallant J, Hsue PY, Shreay S, Meyer N. Comorbidities among US patients with prevalent HIV Infection\u2014A trend analysis. J Infect Dis. 2017;216:1525\u201333. https:\/\/doi.org\/10.1093\/infdis\/jix518.","journal-title":"J Infect Dis"},{"key":"12829_CR73","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/cid\/ciy325","volume":"67","author":"A Ronit","year":"2018","unstructured":"Ronit A, Gerstoft J, Nielsen L, Mohey R, Wiese L, Kvinesdal B, et al. Non-AIDS comorbid conditions in persons living with human immunodeficiency virus (HIV) compared with uninfected individuals 10 years before HIV diagnosis. Clin Infect Dis. 2018;67:1291\u20133. https:\/\/doi.org\/10.1093\/cid\/ciy325.","journal-title":"Clin Infect Dis"},{"key":"12829_CR74","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","volume":"62","author":"SG Deeks","year":"2011","unstructured":"Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. 2011;62:141\u201355. https:\/\/doi.org\/10.1146\/annurev-med-042909-093756.","journal-title":"Annu Rev Med"},{"key":"12829_CR75","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/cid\/cir627","volume":"53","author":"G Guaraldi","year":"2011","unstructured":"Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis Off Publ Infect Dis Soc Am. 2011;53:1120\u20136. https:\/\/doi.org\/10.1093\/cid\/cir627.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"12829_CR76","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1093\/infdis\/jiw286","volume":"214 suppl2","author":"JR Koethe","year":"2016","unstructured":"Koethe JR, Heimburger DC, PrayGod G, Filteau S. From wasting to obesity: the contribution of nutritional status to immune activation in HIV infection. J Infect Dis. 2016;214 suppl2:S75\u201382. https:\/\/doi.org\/10.1093\/infdis\/jiw286.","journal-title":"J Infect Dis"},{"key":"12829_CR77","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/cid\/ciz999","volume":"71","author":"PE Sax","year":"2020","unstructured":"Sax PE, Erlandson KM, Lake JE, Mccomsey GA, Orkin C, Esser S, et al. Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020;71:1379\u201389. https:\/\/doi.org\/10.1093\/cid\/ciz999.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"12829_CR78","doi-asserted-by":"publisher","first-page":"e10106","DOI":"10.1371\/journal.pone.0010106","volume":"5","author":"N Crum-Cianflone","year":"2010","unstructured":"Crum-Cianflone N, Roediger MP, Eberly L, Headd M, Marconi V, Ganesan A, et al. Increasing rates of obesity among HIV-Infected persons during the HIV epidemic. PLoS ONE. 2010;5:e10106. https:\/\/doi.org\/10.1371\/journal.pone.0010106.","journal-title":"PLoS ONE"},{"key":"12829_CR79","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3390\/healthcare8030290","volume":"8","author":"K Mahlangu","year":"2020","unstructured":"Mahlangu K, Modjadji P, Madiba S. The nutritional status of adult antiretroviral therapy recipients with a recent HIV Diagnosis; A Cross-Sectional study in primary health facilities in Gauteng, South Africa. Healthcare. 2020;8:290. https:\/\/doi.org\/10.3390\/healthcare8030290.","journal-title":"Healthcare"},{"key":"12829_CR80","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/HIV.S397511","volume":"15","author":"Y Tegene","year":"2023","unstructured":"Tegene Y, Mengesha S, Putman E, Toma A, Spigt M. Development of hypertension and diabetes Mellitus, and associated Factors, among adult HIV patients in Ethiopia. HIVAIDS Auckl NZ. 2023;15:41\u201351. https:\/\/doi.org\/10.2147\/HIV.S397511.","journal-title":"HIVAIDS Auckl NZ"},{"key":"12829_CR81","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1080\/17441692.2022.2049344","volume":"17","author":"JT Hertz","year":"2022","unstructured":"Hertz JT, Prattipati S, Kweka GL, Mlangi JJ, Tarimo TG, Mmbaga BT, et al. Prevalence and predictors of uncontrolled hypertension, diabetes, and obesity among adults with HIV in Northern Tanzania. Glob Public Health. 2022;17:3747\u201359. https:\/\/doi.org\/10.1080\/17441692.2022.2049344.","journal-title":"Glob Public Health"},{"key":"12829_CR82","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/HIV.S447396","volume":"16","author":"M Haile","year":"2024","unstructured":"Haile M, Degelo T, Adilo TM, Adem FM, Gidisa B. Prevalence of hypertension and its associated factors among adults living with HIV on antiretroviral treatment in selected public hospitals in addis Ababa, Ethiopia. HIVAIDS Auckl NZ. 2024;16:109\u201322. https:\/\/doi.org\/10.2147\/HIV.S447396.","journal-title":"HIVAIDS Auckl NZ"},{"key":"12829_CR83","doi-asserted-by":"publisher","unstructured":"Badacho AS, Mahomed OH. Prevalence of hypertension and diabetes and associated risk factors among people living with human immunodeficiency virus in Southern Ethiopia. Front Cardiovasc Med. 2023;10. https:\/\/doi.org\/10.3389\/fcvm.2023.1173440.","DOI":"10.3389\/fcvm.2023.1173440"},{"key":"12829_CR84","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12902-023-01419-x","volume":"23","author":"J Jumare","year":"2023","unstructured":"Jumare J, Dakum P, Sam-Agudu N, Memiah P, Nowak R, Bada F, et al. Prevalence and characteristics of metabolic syndrome and its components among adults living with and without HIV in Nigeria: a single-center study. BMC Endocr Disord. 2023;23:160.","journal-title":"BMC Endocr Disord"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12829-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12829-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12829-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:02:52Z","timestamp":1773795772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12829-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12829"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12829-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted after obtaining ethical approval from the Ethical Review Committee of Addis Continental Institute of Public Health and the Addis Ababa Public Health Research and Emergency Directorate ethical clearance number 8471\/227 on January 15, 2023. Administrative clearance was secured from Zewditu Memorial Hospital authorities to access medical records and conduct the research. The TB\/HIV unit was formally briefed about the study objectives prior to commencement. The researchers gained access to patients or patient data within the hospital setting after permission was obtained from the hospitals research and training directorate, the HIV\/TB unit and the hospital administration. Written informed consent was obtained from all study participants, and all research procedures strictly adhered to COVID-19 prevention protocols. The study methodology complied with relevant guidelines and regulations, including the principles outlined in the Declaration of Helsinki. Participants newly diagnosed with hypertension, diabetes, or dyslipidemia during the study were appropriately referred for further medical evaluation and management.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"566"}}